---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024517"
form_type: "8-K"
ticker: "NSTM"
cik: "0000912544"
company_name: "NovelStem International Corp."
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T09:16:37.708583+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Arbitrator confirms NovelStem JV's rights to 'Tom Clancy's Net Force' across all media

## Summary
- Arbitrator ruled in favor of Netco Partners (50/50 JV) on contract interpretation; confirms rights to license 'Tom Clancy's Net Force' in TV, film, streaming, gaming, and ancillary rights.
- Franchise has generated over $24M in payments to Netco Partners JV since inception, almost exclusively from book publishing.
- Arbitrator found C.P. Group failed to use 'reasonable, good faith efforts' to exploit the franchise, breaching JV agreement.
- NovelStem plans to actively pursue licensing opportunities to fund commercialization of NewStem stem-cell technology platform.
- NovelStem had 46.9M shares outstanding as of May 12, 2023; trades OTC Pink under NSTM.

## SEC filing metadata
- accession: 0001493152-23-024517
- form_type: 8-K
- ticker: NSTM
- cik: 0000912544
- company_name: NovelStem International Corp.
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/912544/000149315223024517/0001493152-23-024517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/912544/000149315223024517/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024517
- JSON: https://secwatch.observer/filing/0001493152-23-024517.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024517.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.